Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.

about

Arachidonic Acid and Cerebral Ischemia Risk: A Systematic Review of Observational Studies The dopamine D3 receptor knockout mouse mimics aging-related changes in autonomic function and cardiac fibrosis The CB1 antagonist, SR141716A, is protective in permanent photothrombotic cerebral ischemia.

P2860

Q26801643-DB6270FB-9847-46C7-8EC5-BF3126BFE964 Q34983783-10F37B43-9E1E-4293-8DA4-04FD3DA058B9 Q40961956-84CCE850-9CAB-400F-B676-FDACE9453B79

P2860

Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.

Item

http://www.wikidata.org/entity/Q36802414

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.

@ast

Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.

@en

type

Item

label

Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.

@ast

Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.

@en

prefLabel

Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.

@ast

Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.

@en

P1476

Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.

@en

P2093

David A Tulis

http://www.w3.org/2001/XMLSchema#string

Somnath Mukhopadhyay

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of a human cannabinoid receptor which is also expressed in testis

The endocannabinoid system as an emerging target of pharmacotherapy

Pathobiology of ischaemic stroke: an integrated view

Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide

Role of endogenous cannabinoids in synaptic signaling

Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor

An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors

Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1

P304

311-318

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/187152507782109917

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5866345

http://www.w3.org/2001/XMLSchema#string

P698

17979695

http://www.w3.org/2001/XMLSchema#string

P921

endocannabinoids

P932

3638791

http://www.w3.org/2001/XMLSchema#string

Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.

about

P2860

P2860

Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932